feedburner

Enter your email address:

Delivered by FeedBurner

India's Zydus begins human trials for potential COVID-19 vaccine

ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic
and well-tolerated in the pre-clinical toxicity studies, Zydus said.
In the human trials, Zydus will enrol over 1,000 subjects across
multiple clinical study sites in India.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-zydus-begins-human-trials-for-potential-covid-19-vaccine/articleshow/76971798.cms



0 comments:

Post a Comment